Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
That is where we come in
The closest human evidence in its drug class is Athira Pharma's fosgonimeton (ATH-1017), a structurally distinct molecule in the same HGF/c-Met program whose Phase 2/3 LIFT-AD Alzheimer's trial failed its primary endpoint in September 2024 (GST 0.08, P=.70)
By blocking this enzyme, the molecule preserves the cellular NAD+ pool, supports sirtuin activation, and stimulates energy expenditure through improved mitochondrial function
A handful of studies have attempted to explore this relationship, but findings have been mixed and often lack rigorous scientific methodology
Glutathione S-transferase isoenzymes in research subjects lung tumors [PMID: 3409473] Laboratory literature summary: Glutathione S-transferase isoenzymes in research subjects lung tumors
US$ 21.04
US$ 27.23
US$ 22.17
